Maryland BioIndustry News

Mon, 21 May 2012 16:38:00 EDT

Emergent BioSolutions approves $35 million stock buyback
Rockville-based Emergent BioSolutions Inc. has launched a share repurchase program for up to $35 million of the company’s common stock.

Emergent gets FDA approval for modified vaccine dosing
Rockville-based Emergent BioSolutions Inc. which makes the only vaccine licensed by the Food and Drug Administration to protect against anthrax infection, has received FDA approval for a new, shorter-dosing schedule.

Human Genome Sciences enters talks with potential suitors
Human Genome Sciences Inc. entered into confidentiality agreements with “certain parties” and is providing an opportunity to engage in due diligence reviews, the Rockville-based company said Thursday.

World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal
Osiris Therapeutics Inc. announced today it has received market authorization from Health Canada to market its stem cell therapy Prochymal® (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children.

Sucampo Pharmaceuticals cuts losses
Bethesda-based Sucampo Pharmaceuticals Inc., with one drug to treat bowel dysfunction on the market and another heading toward a regulatory review, cut losses last quarter on lower research and development costs.

EntreMed keeps its listing
Rockville-based EntreMed Inc. which was warned in November it was at risk of losing its Nasdaq stock market listing, will now keep it.

GenVec revenue falls, loss widens
Gaithersburg-based GenVec Inc. posted a wider loss in its latest quarter as cost reductions failed to make up for a drop in revenue.

Biowatch: Supernus debuts on the Nasdaq, awaits ruling on epilepsy drugs
Supernus Pharmaceuticals, the Rockville biotech that’s developing drugs to treat epilepsy, depression and attention deficit hyperactivity disorder, got off to a solid start in its first week of trading as a public company.

BioMed adds two Rockville buildings in $26.2M deal
BioMed Realty Trust of San Diego has announced plans to buy two more Rockville laboratory and office buildings for $26.2 million.

Supernus moves from IPO to FDA
Supernus Pharmaceuticals Inc. capped off its first week on the Nasdaq up nearly $1 from its initial public offering price. With its IPO in the bag, the Rockville biotech now turns to a bigger gamble: seeing two drugs through Food and Drug Administration approval and onto the commercial market.

Emergent Biosolutions Executive Chairman Fuad El-Hibri Named Tech Council of Maryland's Executive of the Year
Emergent BioSolutions Inc. announced today that Fuad El-Hibri, its executive chairman of the board, has been recognized as Executive of the Year by the Tech Council of Maryland (TCM), the state’s largest technology and life science association.

United Therapeutics reports strong quarter
Silver Spring-based United Therapeutics Corp., aiming for $1 billion in annual revenue by next year, is well on its way toward that mark.

Neuralstem Chief Scientific Officer To Present At Spinal Cord Injury Conference In China
Neuralstem, Inc. (NYSE Amex: CUR) announced that Karl Johe, PhD, Chairman and Chief Scientific Officer, will present at the Fourth International Spinal Cord Injury Treatments and Trials Symposium, in Xi'an, China on Friday, May 4, at 1:00 PM.

Proton treatment center construction to start on Baltimore's west side
The University of Maryland School of Medicine and Advanced Particle Therapy LLC of San Diego plan to start construction on a new $200 million-plus proton treatment center on Baltimore’s west side.

Cytomedix wound therapy shows promise in diabetics
Cytomedix has reported positive data from a clinical trial of its wound care therapy in Japan — and a major stock sale involving a 15.3 percent stake in the Gaithersburg biotech.

Gaithersburg offers incentive to Novavax for move
Rockville-based Novavax Inc. is in negotiations with Gaithersburg officials on an agreement that would give the biopharmaceutical company financial incentives to help renovate about 74,000 square feet of manufacturing, lab and office space at 20 and 22 Firstfield Road, The Gazette reports.

Vital Signs by Phone, Then, With a Click, a Doctor’s Appointment
If ever an industry were ready for disruption, it is the American health care industry. Americans spend about $7,600 a year per person on health care, one in two adults lives with a chronic disease and the average wait time to see a doctor in a metropolitan area is 20 days.

Montgomery biotechs get $6M boost from first local tax program
Ten biotechnology companies in Montgomery County last year received almost $6 million from investors who were spurred by the state and county’s biotech investment tax credit programs, officials said Monday.

Maryland Workforce News

Tue, 01 Nov 2011 15:27:00 EDT

More info to come...

Maryland General News

Mon, 21 May 2012 15:58:00 EDT

O'Malley discusses medical innovation jobs
Gov. Martin O’Malley joined the governors of Delaware and West Virginia in Baltimore on Friday to discuss how states have found biopharmaceutical research companies to be an important source of jobs, tax revenue and research spending.

State Establishes New Tech Transfer Fund
The state and five universities are spending upwards of $5.8 million to help startups move from concept to a company.

Mikulski Continues Maryland Biotechnology Listening Tour in Montgomery County
U.S. Senator Barbara A. Mikulski (D-Md.), a senior member of the Senate Health, Education, Labor and Pensions (HELP) Committee, continued her Maryland biotechnology listening tour at a roundtable discussion with Montgomery County pharmaceutical companies at Human Genome Sciences, Inc.

Governor Martin O'Malley Announces $84 Million in Investment for Maryland's Innovation Economy
Governor Martin O’Malley and Peter Greenleaf, chairman of the Maryland Venture Fund Authority, today announced that $84 million has been raised for Maryland’s Innovation Economy through InvestMaryland – an historic initiative created by the Governor and passed by the General Assembly last year to invest in the State’s promising start-up and early stage companies.

Bio In Maryland

Maryland Academic News

Maryland BioIndustry News

Maryland Workforce News

Maryland General News